Vasomedical (VASO)
(Delayed Data from OTC)
$0.27 USD
+0.01 (5.10%)
Updated May 13, 2024 03:54 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for Vasomedical Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 25 | 20 | 7 | 8 | 2 |
Receivables | 13 | 16 | 15 | 10 | 16 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 1 | 1 | 1 | 1 | 2 |
Other Current Assets | 5 | 4 | 5 | 4 | 4 |
Total Current Assets | 45 | 42 | 28 | 22 | 24 |
Net Property & Equipment | 1 | 1 | 2 | 4 | 5 |
Investments & Advances | 1 | 1 | 1 | 1 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 5 | 5 | 0 | 0 | 0 |
Intangibles | 17 | 17 | 18 | 20 | 22 |
Deposits & Other Assets | 5 | 5 | 2 | 2 | 3 |
Total Assets | 76 | 73 | 52 | 50 | 54 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 6 | 4 |
Accounts Payable | 3 | 2 | 3 | 6 | 6 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 10 | 13 | 10 | 6 | 7 |
Income Taxes Payable | 1 | 1 | 1 | 1 | 1 |
Other Current Liabilities | 16 | 15 | 17 | 12 | 12 |
Total Current Liabilities | 30 | 32 | 31 | 32 | 32 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 16 | 16 | 8 | 6 | 7 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 6 | 8 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 2 | 1 | 1 | 1 | 1 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 49 | 50 | 41 | 45 | 49 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 64 | 64 | 64 | 64 | 64 |
Retained Earnings | -35 | -39 | -51 | -57 | -56 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 2 | 2 | 2 | 2 | 2 |
Total Shareholder's Equity | 27 | 23 | 11 | 5 | 6 |
Total Liabilities & Shareholder's Equity | 76 | 73 | 52 | 50 | 54 |
Total Common Equity | 27 | 23 | 11 | 5 | 6 |
Shares Outstanding | 185.60 | 175.10 | 175.10 | 185.20 | 183.50 |
Book Value Per Share | 0.14 | 0.13 | 0.06 | 0.03 | 0.03 |
Fiscal Year End for Vasomedical Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 25 | 27 | 26 | 18 |
Receivables | NA | 13 | 9 | 10 | 14 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 1 | 1 | 2 | 2 |
Other Current Assets | NA | 5 | 6 | 5 | 5 |
Total Current Assets | NA | 45 | 43 | 43 | 38 |
Net Property & Equipment | NA | 1 | 1 | 1 | 1 |
Investments & Advances | NA | 1 | 1 | 1 | 1 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 5 | 5 | 5 | 5 |
Intangibles | NA | 17 | 17 | 17 | 17 |
Deposits & Other Assets | NA | 5 | 4 | 5 | 5 |
Total Assets | NA | 76 | 73 | 74 | 70 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 3 | 2 | 3 | 2 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 10 | 8 | 8 | 8 |
Income Taxes Payable | NA | 1 | 1 | 1 | 1 |
Other Current Liabilities | NA | 16 | 19 | 17 | 14 |
Total Current Liabilities | NA | 30 | 30 | 29 | 26 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 16 | 15 | 17 | 17 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 2 | 2 | 2 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 49 | 47 | 48 | 46 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 64 | 64 | 64 | 64 |
Retained Earnings | NA | -35 | -36 | -37 | -39 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 2 | 2 | 2 | 2 |
Total Shareholder's Equity | NA | 27 | 26 | 25 | 23 |
Total Liabilities & Shareholder's Equity | NA | 76 | 73 | 74 | 70 |
Total Common Equity | 0 | 27 | 26 | 25 | 23 |
Shares Outstanding | 185.60 | 185.60 | 185.60 | 185.40 | 175.10 |
Book Value Per Share | 0.00 | 0.14 | 0.14 | 0.14 | 0.13 |